These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
828 related items for PubMed ID: 33307174
1. The NLRP3 inflammasome drives inflammation in ischemia/reperfusion injury after transient middle cerebral artery occlusion in mice. Franke M, Bieber M, Kraft P, Weber ANR, Stoll G, Schuhmann MK. Brain Behav Immun; 2021 Feb; 92():223-233. PubMed ID: 33307174 [Abstract] [Full Text] [Related]
2. Delayed NLRP3 inflammasome inhibition ameliorates subacute stroke progression in mice. Bellut M, Bieber M, Kraft P, Weber ANR, Stoll G, Schuhmann MK. J Neuroinflammation; 2023 Jan 04; 20(1):4. PubMed ID: 36600259 [Abstract] [Full Text] [Related]
3. Aloe-emodin alleviates cerebral ischemia-reperfusion injury by regulating microglial polarization and pyroptosis through inhibition of NLRP3 inflammasome activation. Li X, Yao M, Li L, Ma H, Sun Y, Lu X, Jing W, Nie S. Phytomedicine; 2024 Jul 04; 129():155578. PubMed ID: 38621328 [Abstract] [Full Text] [Related]
4. Inhibition of the NLRP3 inflammasome reduces brain edema and regulates the distribution of aquaporin-4 after cerebral ischaemia-reperfusion. Wang H, Chen H, Jin J, Liu Q, Zhong D, Li G. Life Sci; 2020 Jun 15; 251():117638. PubMed ID: 32251636 [Abstract] [Full Text] [Related]
5. Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke. Ismael S, Zhao L, Nasoohi S, Ishrat T. Sci Rep; 2018 Apr 13; 8(1):5971. PubMed ID: 29654318 [Abstract] [Full Text] [Related]
6. Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke. Fann DY, Lee SY, Manzanero S, Tang SC, Gelderblom M, Chunduri P, Bernreuther C, Glatzel M, Cheng YL, Thundyil J, Widiapradja A, Lok KZ, Foo SL, Wang YC, Li YI, Drummond GR, Basta M, Magnus T, Jo DG, Mattson MP, Sobey CG, Arumugam TV. Cell Death Dis; 2013 Sep 05; 4(9):e790. PubMed ID: 24008734 [Abstract] [Full Text] [Related]
7. NLRP3 inflammasome activates interleukin-23/interleukin-17 axis during ischaemia-reperfusion injury in cerebral ischaemia in mice. Wang H, Zhong D, Chen H, Jin J, Liu Q, Li G. Life Sci; 2019 Jun 15; 227():101-113. PubMed ID: 31002919 [Abstract] [Full Text] [Related]
8. Neuroprotective Effects of Vinpocetine Against Ischemia-Reperfusion Injury Via Inhibiting NLRP3 Inflammasome Signaling Pathway. Hou B, Li D, Wang D, Jiang C, Wang G, Wang D, Yan G, Guo X, Zhao L, Wan Z, Fan C, Cao W, Ren H. Neuroscience; 2023 Aug 21; 526():74-84. PubMed ID: 37290685 [Abstract] [Full Text] [Related]
9. Inhibition of NLRP3 Inflammasome Ameliorates Cerebral Ischemia-Reperfusion Injury in Diabetic Mice. Hong P, Li FX, Gu RN, Fang YY, Lai LY, Wang YW, Tao T, Xu SY, You ZJ, Zhang HF. Neural Plast; 2018 Aug 21; 2018():9163521. PubMed ID: 29853850 [Abstract] [Full Text] [Related]
10. Transmission of NLRP3-IL-1β Signals in Cerebral Ischemia and Reperfusion Injury: from Microglia to Adjacent Neuron and Endothelial Cells via IL-1β/IL-1R1/TRAF6. Pan J, Peng J, Li X, Wang H, Rong X, Peng Y. Mol Neurobiol; 2023 May 21; 60(5):2749-2766. PubMed ID: 36717480 [Abstract] [Full Text] [Related]
11. Cepharanthine attenuates cerebral ischemia/reperfusion injury by reducing NLRP3 inflammasome-induced inflammation and oxidative stress via inhibiting 12/15-LOX signaling. Zhao J, Piao X, Wu Y, Liang S, Han F, Liang Q, Shao S, Zhao D. Biomed Pharmacother; 2020 Jul 21; 127():110151. PubMed ID: 32559840 [Abstract] [Full Text] [Related]
12. NLRP3 inflammasome deficiency attenuates cerebral ischemia-reperfusion injury by inhibiting ferroptosis. Wang Z, Li Y, Ye Y, Zhu H, Zhang J, Wang H, Lei J, Gu L, Zhan L. Brain Res Bull; 2023 Feb 21; 193():37-46. PubMed ID: 36435361 [Abstract] [Full Text] [Related]
13. Sulforaphane improves outcomes and slows cerebral ischemic/reperfusion injury via inhibition of NLRP3 inflammasome activation in rats. Yu C, He Q, Zheng J, Li LY, Hou YH, Song FZ. Int Immunopharmacol; 2017 Apr 21; 45():74-78. PubMed ID: 28189971 [Abstract] [Full Text] [Related]
14. Kv1.3 channel blockade alleviates cerebral ischemia/reperfusion injury by reshaping M1/M2 phenotypes and compromising the activation of NLRP3 inflammasome in microglia. Ma DC, Zhang NN, Zhang YN, Chen HS. Exp Neurol; 2020 Oct 21; 332():113399. PubMed ID: 32652099 [Abstract] [Full Text] [Related]
15. Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia/reperfusion injury. Gong Z, Pan J, Shen Q, Li M, Peng Y. J Neuroinflammation; 2018 Aug 28; 15(1):242. PubMed ID: 30153825 [Abstract] [Full Text] [Related]
16. IMM-H004 therapy for permanent focal ischemic cerebral injury via CKLF1/CCR4-mediated NLRP3 inflammasome activation. Ai QD, Chen C, Chu S, Zhang Z, Luo Y, Guan F, Lin M, Liu D, Wang S, Chen N. Transl Res; 2019 Oct 28; 212():36-53. PubMed ID: 31176667 [Abstract] [Full Text] [Related]
17. Lipocalin-2-mediated astrocyte pyroptosis promotes neuroinflammatory injury via NLRP3 inflammasome activation in cerebral ischemia/reperfusion injury. Li J, Xu P, Hong Y, Xie Y, Peng M, Sun R, Guo H, Zhang X, Zhu W, Wang J, Liu X. J Neuroinflammation; 2023 Jun 23; 20(1):148. PubMed ID: 37353794 [Abstract] [Full Text] [Related]
18. PHLDA1 Blockade Alleviates Cerebral Ischemia/Reperfusion Injury by Affecting Microglial M1/M2 Polarization and NLRP3 Inflammasome Activation. Zhao H, Liu Y, Chen N, Yu H, Liu S, Qian M, Zhang Z. Neuroscience; 2022 Apr 01; 487():66-77. PubMed ID: 35093445 [Abstract] [Full Text] [Related]
19. Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2/STAT3 Pathway Inhibition. Zhu H, Jian Z, Zhong Y, Ye Y, Zhang Y, Hu X, Pu B, Gu L, Xiong X. Front Immunol; 2021 Apr 01; 12():714943. PubMed ID: 34367186 [Abstract] [Full Text] [Related]
20. Vagus nerve stimulation as a promising neuroprotection for ischemic stroke via α7nAchR-dependent inactivation of microglial NLRP3 inflammasome. Xia XM, Duan Y, Wang YP, Han RX, Dong YF, Jiang SY, Zheng Y, Qiao C, Cao L, Lu X, Lu M. Acta Pharmacol Sin; 2024 Jul 01; 45(7):1349-1365. PubMed ID: 38504011 [Abstract] [Full Text] [Related] Page: [Next] [New Search]